The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery
St. Chao et al., The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery, INT J CANC, 96(3), 2001, pp. 191-197
Radiation necrosis and recurrent brain tumor have similar symptoms and are
indistinguishable on both magnetic resonance imaging (MRI) and computed tom
ograph scans. F-18-fluorodeoxyglucose (FDG) positron emission tomography (P
ET) has been proposed as a diagnostic alternative, particularly when co-reg
istered with MRT. We studied 47 patients with brain tumors treated with ste
reotactic radiosurgery and followed with FDG PET. For all tumor types, the
sensitivity of FDG PET for diagnosing tumor was 75% and the specificity was
81%. For brain metastasis without MRI co-registration, FDG PET had a sensi
tivity of 65% and a specificity of 80%. For brain metastasis with MRI co-re
gistration, FDG PET had a sensitivity of 86% and specificity of 80%. MRI co
registration appears to improve the sensitivity of FDG PET, making it a use
ful modality to distinguish between radiation necrosis and recurrent brain
metastasis. (C) 2001 Wiley-Liss, Inc.